Evogene Ltd. (EVGN) Financials
EVGN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 57.7 million | 21.9 million |
2023-06-30 | 53.3 million | 22.2 million |
2023-03-31 | 49.5 million | 21.0 million |
2022-12-31 | 56.1 million | 21.3 million |
EVGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -4.5 million | 545000 |
2023-06-30 | -5.2 million | 801000 |
2023-03-31 | -6.6 million | 418000 |
2022-12-31 | -2.5 million | 291000 |
EVGN Net Income
No data available :(
EVGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 37.2 million | - | 1.2 million |
2023-06-30 | 33.9 million | - | 1.5 million |
2023-03-31 | - | - | 1.6 million |
2022-12-31 | 35.4 million | - | 1.8 million |
EVGN Shares Outstanding
EVGN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 216000 | 5.1 million | 1.5 million | 850000 |
2023-06-30 | 124000 | 5.4 million | 1.8 million | 928000 |
2023-03-31 | 359000 | 4.8 million | 1.5 million | 800000 |
2022-12-31 | 199000 | 4.8 million | 1.7 million | 1.2 million |
EVGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 3.8 million | 511000 |
2023-06-30 | 654000 | 461000 |
2023-03-31 | 641000 | 322000 |
2022-12-31 | 660000 | 364000 |
EVGN
Price: $0.71
52 week price:
Earnings Per Share: -0.52 USD
P/E Ratio: -1.62
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 71621
Ebitda: -8.5 millionMarket Capitalization: 38.7 million